Atherosclerosis. 2026 May 24:120745. doi: 10.1016/j.atherosclerosis.2026.120745. Online ahead of print.
ABSTRACT
Approximately 50 million people are living with dementia worldwide, a number projected to reach more than 150 million by 2050. Dementia has emerged as one of the most pressing public health challenges globally, and it is increasingly recognized that dementia share several modifiable risk factors with cardiovascular diseases. It is now suggested that 45% of all dementia cases can be prevented by acting on midlife cardiovascular risk factors such as hypertension, dyslipidemia, physical inactivity, and diabetes. To successfully prevent dementia, it is important to discriminate true causal modifiable risk factors from non-causal associations. This can be facilitated by the application of robust Mendelian randomization (MR) strategies on individual level data in large-scale population biobanks. Once identified, the causal risk factors can be included in risk prediction tools to identify those high-risk individuals that will benefit the most from intensive early preventive interventions. In this review, we explore the scientific human evidence on well-established and emerging cardiovascular risk factors and risk of dementia. We discuss the important genetic risk factors for dementia and how they can be used in future risk prediction strategies. We further highlight the statistical caveats when assessing diseases of late-life and with long prodromal phases such as dementia. We conclude that the scientific evidence supports midlife low educational level, hypertension, diabetes, smoking, high BMI, and high concentrations of LDL cholesterol and triglycerides as causal risk factors of dementia. Furthermore, the overlap between cardiovascular and dementia risk factors encourages genomics-informed drug discovery as a therapeutic approach for dementia.
PMID:42177119 | DOI:10.1016/j.atherosclerosis.2026.120745